Obtaining Somatosensory Stimulation-Related Signals from Orofacial Skin Stretching
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:23 min • July 8th, 2025
Loading...
Overview
This study investigates the use of electroencephalography (EEG) to record brain activity during somatosensory stimulation. Participants undergo facial skin stretching to activate mechanoreceptors, allowing for the analysis of electrical signals generated in response to the stimulation.
Key Study Components
Area of Science
- Neuroscience
- Electrophysiology
- Somatosensory processing
Background
- Electroencephalography (EEG) is a non-invasive method to measure brain activity.
- Somatosensory stimulation can provide insights into sensory processing mechanisms.
- Understanding the electrical signals generated by mechanoreceptors is crucial for neuroscience research.
- Minimizing movement artifacts is essential for accurate EEG recordings.
Purpose of Study
- To explore the relationship between facial skin stimulation and brain activity.
- To record event-related potentials (ERPs) in response to somatosensory stimuli.
- To assess participant reactions and judgments during stimulation.
Methods Used
- Participants wear an EEG cap with electrodes to record brain activity.
- Facial skin is stimulated using a robotic device connected to plastic tabs.
- Participants are instructed to fixate on a point to reduce eye movement artifacts.
- Electrical signals are recorded at 512 Hertz sampling during stimulation.
Main Results
- Electrical signals from EEG electrodes reveal responses to facial skin stimulation.
- Participant reaction times and judgments are recorded for analysis.
- Stimulation successfully activates cutaneous mechanoreceptors.
- Data collected supports further investigation into sensory processing.
Conclusions
- The study demonstrates effective methods for recording brain responses to somatosensory stimuli.
- Findings contribute to understanding the neural mechanisms underlying sensory processing.
- Future research can build on these methods to explore other sensory modalities.
Frequently Asked Questions
What is the purpose of using EEG in this study?
EEG is used to measure brain activity in response to somatosensory stimulation.
How is facial skin stimulation administered?
Facial skin is stimulated using a robotic device that pulls strings attached to plastic tabs on the skin.
What precautions are taken to minimize artifacts during recording?
Participants' heads are secured in a headrest, and they are instructed to fixate on a point to reduce eye movement artifacts.
What type of data is collected during the experiment?
Data collected includes electrical signals from EEG electrodes, participant judgments, and reaction times.
What are the implications of this research?
The research provides insights into sensory processing and the neural mechanisms involved in somatosensory stimulation.
Executive Industry Relevance
This method enables quantitative assessment of somatosensory pathway engagement through controlled cutaneous mechanoreceptor activation, supporting target validation in neuroscience drug discovery. By capturing event-related potentials (ERPs) in response to orofacial skin stretch, it provides a disease-relevant system for evaluating central nervous system penetrance and target engagement of neuromodulatory compounds. The approach offers mechanistic de-risking value by linking peripheral stimulation to cortical responses, informing go/no-go decisions in early discovery.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses regarding somatosensory pathway modulation and target engagement.
- Operational Value: Enables biological de-risking through objective measurement of neural activation patterns.
- Predictive Value: Supports portfolio triage by quantifying CNS response to mechanosensory stimuli.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream compound screening via standardized stimulation protocols.
- Quantitative Outputs: Generates reproducible ERP measurements enabling reliable compound evaluation.
- Scalability: Facilitates platform reuse through robotic control and EEG-based readouts.
Translational & Preclinical Research
- Translational Continuity: Connects discovery-phase mechanoreceptor activation to preclinical validation through disease-relevant somatosensory signaling.
- Biomarker Alignment: Supports translational biomarker development via event-related potential readouts correlated with stimulation parameters.
- Risk-Adjusted Advancement: Informs preclinical go/no-go decisions by quantifying target-mediated neural responses.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target hypothesis testing through lead identification to preclinical validation by providing quantifiable neural readouts of somatosensory pathway modulation.
- Discovery Biology: Supports hypothesis testing and pathway clarification via controlled activation of cutaneous mechanoreceptors and cortical response measurement.
- Screening: Enables assay readiness through standardized stimulation protocols and reproducible EEG-based outputs.
- Analytics: Delivers quantitative event-related potential measurements that allow cross-condition comparison of neural activation.
- Translational Research: Connects to preclinical continuity through disease-relevant somatosensory system modeling and biomarker-aligned readouts.
- Enterprise Reuse: Functions as a reusable capability for mechanosensory target validation across multiple discovery programs.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation, reduction of mechanistic ambiguity in somatosensory pathways.
- Operational Value: Standardization, reproducibility, and scalability of neural response measurements.
- Strategic Value: Improved go/no-go decisions, capital efficiency, and reduced late-stage biological risk in CNS programs.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on quantifiable target engagement.
Implementation Considerations
- Requires expertise in electroencephalography, somatosensory neuroscience, and robotic stimulation systems.
- Needs EEG acquisition hardware, robotic skin stretch devices, and synchronized stimulus presentation software.
- Demands cross-team standardization for electrode placement, stimulation parameters, and artifact minimization protocols.
- Involves adaptation considerations for different facial innervation patterns and participant variability.
- Limited by the need for participant stillness and potential discomfort from prolonged skin stretching.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in somatosensory ERP studies?
Null hypothesis testing determines whether observed event-related potential changes exceed baseline variability, confirming statistically significant neural activation following mechanoreceptor stimulation. This supports objective target validation by distinguishing true signal from noise in early discovery.
How does independent variable isolation fit the discovery pipeline for mechanosensory target assessment?
Isolating the skin stretch stimulus as the independent variable ensures that measured ERP changes are attributable to mechanoreceptor activation rather than confounding factors. This enables clear target engagement assessment in hypothesis-driven discovery workflows.
What quantitative dependent variable measurements enable target validation in somatosensory stimulation studies?
Event-related potential amplitudes and latencies serve as quantitative dependent variables that reflect cortical response magnitude and timing to cutaneous mechanoreceptor input. These measurements allow dose-response modeling and compound effect comparison in screening applications.
Why do replication requirements matter for cross-functional collaboration in somatosensory ERP assays?
Replication across sessions and participants ensures assay reliability and reproducibility, which are essential for consistent data interpretation between discovery biology, screening, and translational teams. Consistent ERP responses build confidence in target validation outcomes.
What statistical analysis capabilities are required before implementing somatosensory stimulation ERP assays in drug discovery?
Pre-implementation requires capability for time-locked averaging, baseline correction, and statistical comparison of ERP components across conditions (e.g., t-tests or ANOVA). These analyses enable detection of stimulation-evoked neural responses and support go/no-go decision-making.
08:17
A Semantic Priming Event-related Potential (ERP) Task to Study Lexico-semantic and Visuo-semantic Processing in Autism Spectrum Disorder
Related Videos
0 Views
08:13
Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
Related Videos
0 Views
11:39
Assessment of Audio-Tactile Sensory Substitution Training in Participants with Profound Deafness Using the Event-Related Potential Technique
Related Videos
0 Views
06:56
Somatosensory Event-related Potentials from Orofacial Skin Stretch Stimulation
Related Videos
0 Views
08:05
Testing Tactile Masking between the Forearms
Related Videos
0 Views
09:16
Multi-Modal Signals for Analyzing Pain Responses to Thermal and Electrical Stimuli
Related Videos
0 Views
04:27
Using Facial Electromyography to Assess Facial Muscle Reactions to Experienced and Observed Affective Touch in Humans
Related Videos
0 Views
06:31
Assessment of Midline Lingual Point-Pressure Somatosensation Using Von Frey Hair Monofilaments
Related Videos
0 Views
07:39
Assessment of Nerve Injury-Induced Mechanical Hypersensitivity in Rats Using an Orofacial Operant Pain Assay
Related Videos
0 Views
06:13
Combining a Breath-Synchronized Olfactometer with Brain Simulation to Study the Impact of Odors on Corticospinal Excitability and Effective Connectivity
Related Videos
0 Views
Last updated: 15 August 2026